Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH) announced the board of directors has appointed James M. Frincke Ph.D. as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE